Digital Content 
NEWS #PharmaBuzz
25 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250623706166/en/BeOne-Medicines-Receives-Positive-CHMP-Opinion-for-Tablet-Formulation-of-BRUKINSA
12 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250612215960/en/BeOne-Medicines-Showcases-Breakthrough-Data-in-CLL-and-MCL-at-EHA-2025
11 Jun 2025
// INDPHARMAPOST
https://www.indianpharmapost.com/news/glenmark-pharmaceuticals-to-launch-dcgi-approved-brukinsa-in-india-for-treatment-of-hematological-malignancies-17261
11 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250611860939/en/U.S.-FDA-Approves-Tablet-Formulation-of-BeOnes-BRUKINSA-for-All-Approved-Indications
31 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250531886517/en/BeOne-Medicines-Presents-New-SEQUOIA-Study-Results-Reinforcing-BRUKINSAs-Differentiated-Profile-with-or-without-Venetoclax-in-Frontline-CLL-at-ASCO-2025
22 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250522213317/en/BeiGene-Presents-Pioneering-Cancer-Research-at-ASCO-2025-Redefining-Treatment-Across-Hematology-and-Solid-Tumors
Share 